科陸電子(002121.SZ)收到中標通知書 中標額約1.11億元
格隆匯1月6日丨科陸電子(002121.SZ)公佈,2019年12月30日,中國南方電網有限責任公司在其電子商務平台公告了“南方電網公司2019年計量產品(電能表)第二批框架招標項目中標候選人公示”,根據公示內容,公司為上述招標項目的中標候選人,預計中標金額合計約人民幣1.11億元。
近日,公司收到了招標代理人南方電網物資有限公司發來的《中標通知書》。
此次項目中標金額約人民幣1.11億元,約佔公司2018年度經審計營業收入的2.92%。該項目中標合同的履行預計會對公司經營業績產生積極影響,但不影響公司經營的獨立性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.